№ files_lp_3_process_7_056349
Transcript of a virtual investor conference call presenting the corporate history, management background, manufacturing operations, regulatory certifications, export registrations, and growth strategy of Curis Lifesciences Ltd following its November IPO.
Organization: Finportal
Event Name: VALUEPORTAL – Investor-Company Connect
Type of Document: Transcript of virtual investor presentation and Q&A session
Company Presented: Curis Lifesciences Ltd
Industry: Pharmaceuticals
Location of Company: Sanand, Gujarat, India
Date of Event: November (post-IPO period)
Key Representatives: Mr. Jaimik Patel (Whole Time Director); Mr. Pragnesh Sharma (Chief Financial Officer); Mr. Piyush Antala (Whole Time Director)
Other Directors Mentioned: Mr. Dharmesh; Mr. Siddhant Pawasia
Incorporation History: Origin as Loreto Pharmaceutical partnership firm in 2010; converted to Curis Lifesciences Private Limited in 2016
Manufacturing License: Granted September 2017
Certifications: WHO-GMP accreditation since 2017
Registered Export Markets: Kenya; Nigeria; Yemen; Philippines; Ghana (registration in process)
Business Activities: Loan licensing (job work); domestic contract manufacturing; merchant export contract manufacturing; own-brand exports
IPO Status: Initial Public Offering completed in November prior to the event
Target Markets: India; Africa; regulated international markets
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.